Namibia - English - Namibia Medicines Regulatory Council

aspen pharmacare - cefazolin sodium injection - injection - cefazolin sodium injection equiv. to cefazolin 1000mg per vial

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - cefazolin sodium 1048mg equivalent to cefazolin 1 g - powder for injection - 1 g - active: cefazolin sodium 1048mg equivalent to cefazolin 1 g

United States - English - NLM (National Library of Medicine)

sandoz inc - cefazolin sodium (unii: p380m0454z) (cefazolin - unii:ihs69l0y4t) - cefazolin for injection, usp is indicated in the treatment of the following infections due to susceptible organisms: respiratory tract infections: due to s. pneumoniae, klebsiella species, h. influenzae, s. aureus (penicillin-sensitive and penicillin-resistant), and group a beta-hemolytic streptococci. injectable benzathine penicillin is considered to be the drug of choice in treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cefazolin for injection, usp is effective in the eradication of streptococci from the nasopharynx; however, data establishing the efficacy of cefazolin for injection, usp in the subsequent prevention of rheumatic fever are not available at present. urinary tract infections: due to e. coli, p. mirabilis, klebsiella species, and some strains of enterobacter and enterococci. skin and skin structure infections: due to s. aureus (penicillin-sensitive and penicillin-resistant), group a beta-hemolytic streptococci, and other strains of str

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - cefazolin sodium 524mg equivalent to cefazolin 500 mg - powder for injection - 0.5 g - active: cefazolin sodium 524mg equivalent to cefazolin 500 mg - due to s. pneumoniae, klebsiella sp, h. influenzae, staph. aureus (including penicillinaseproducing strains), and group a ?-haemolytic streptococci. injectable penicillin g benzathine is considered to be the medicine of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cefazolin is effective in the eradication of streptococci from the nasopharynx; however, data establishing the efficacy of cefazolin in the subsequent prevention of rheumatic fever are not available at present.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - cefazolin sodium 1048mg equivalent to cefazolin 1000 mg - powder for injection - 1 g - active: cefazolin sodium 1048mg equivalent to cefazolin 1000 mg - due to s. pneumoniae, klebsiella sp, h. influenzae, staph. aureus (including penicillinaseproducing strains), and group a ?-haemolytic streptococci. injectable penicillin g benzathine is considered to be the medicine of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cefazolin is effective in the eradication of streptococci from the nasopharynx; however, data establishing the efficacy of cefazolin in the subsequent prevention of rheumatic fever are not available at present.

Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - cefazolin sodium, quantity: 1048 mg (equivalent: cefazolin, qty 1000 mg) - injection, powder for - excipient ingredients: - cephazolin sodium injection is indicated in the treatment of the following serious infections due to susceptible organisms: 1. respiratory tract infections due to s. pneumoniae, klebsiella species, h. influenzae, staph. aureus (penicillin-sensitive and penicillin-resistant), and group a beta-haemolytic streptococci. injectable benzathine penicillin is considered to be the drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cephazolin sodium is effective in the eradication of streptococci from the nasopharynx; however, data establishing the efficacy of cephazolin sodium in the subsequent prevention of rheumatic fever are not available at present 2. gentinourinary tract infections due to esch. coli, pr. mirabilis, klebsiella species and some strains of enterobacter and enterococci. 3. skin and soft-tissue infections due to staph. aureus (penicillin-sensitive and penicillin-resistant) and group a beta-haemolytic streptococci and other strains of streptococci. 4. bone and joint infections due to staph. aureus. 5. septicaemia due to s. pneumoniae, staph. aureus (penicillin-sensitive and penicillin- resistant), pr. mirabilia, esch. coli and klebsiella species. 6. endocarditis due to staph. aureus (penicillin-sensitive and penicillin-resistant) and group a beta-haemolytic streptococci. appropriate culture and susceptibility studies should be performed to determine susceptibility of the causative organism to cephazolin sodium.

Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - cefazolin sodium, quantity: 524 mg (equivalent: cefazolin, qty 500 mg) - injection, powder for - excipient ingredients: - cephazolin sodium injection is indicated in the treatment of the following serious infections due to susceptible organisms: 1. respiratory tract infections due to s. pneumoniae, klebsiella species, h. influenzae, staph. aureus (penicillin-sensitive and penicillin-resistant), and group a beta-haemolytic streptococci. injectable benzathine penicillin is considered to be the drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cephazolin sodium is effective in the eradication of streptococci from the nasopharynx; however, data establishing the efficacy of cephazolin sodium in the subsequent prevention of rheumatic fever are not available. 2. gentinourinary tract infections due to esch. coli, pr. mirabilis, klebsiella species and some strains of enterobacter and enterococci. 3. skin and soft-tissue infections due to staph. aureus (penicillin-sensitive and penicillin-resistant) and group a beta-haemolytic streptococci and other strains of streptococci. 4. bone and joint infections due to staph. aureus. 5. septicaemia due to s. pneumoniae, staph. aureus (penicillin-sensitive and penicillin- resistant), pr. mirabilia, esch. coli and klebsiella species. 6. endocarditis due to staph. aureus (penicillin-sensitive and penicillin-resistant) and group a beta-haemolytic streptococci. appropriate culture and susceptibility studies should be performed to determine susceptibility of the causative organism to cephazolin sodium.

United States - English - NLM (National Library of Medicine)

sandoz inc - cefazolin sodium (unii: p380m0454z) (cefazolin - unii:ihs69l0y4t) - cefazolin for injection is indicated in the treatment of the following infections due to susceptible organisms: respiratory tract infections: due to s. pneumoniae, klebsiella species, h. influenzae, s. aureus (penicillin-sensitive and penicillin-resistant), and group a beta-hemolytic streptococci . injectable benzathine penicillin is considered to be the drug of choice in treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cefazolin for injection is effective in the eradication of streptococci from the nasopharynx; however, data establishing the efficacy of cefazolin for injection in the subsequent prevention of rheumatic fever are not available at present. urinary tract infections: due to e. coli, p. mirabilis, klebsiella species, and some strains of enterobacter and enterococci . skin and skin structure infections: due to s. aureus (penicillin-sensitive and penicillin-resistant), group a beta-hemolytic streptococci , and other strains of streptococci

United States - English - NLM (National Library of Medicine)

cardinal health - cefazolin sodium (unii: p380m0454z) (cefazolin - unii:ihs69l0y4t) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of cefazolin for injection usp and other antibacterial drugs, cefazolin for injection usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. cefazolin for injection usp is indicated for the treatment of the following infections when caused by susceptible bacteria. respiratory tract infections due to streptococcus pneumoniae, staphylococcus aureus and streptococcus pyogenes . injectable benzathine penicillin is considered the drug of choice in treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cefazolin is effective in the eradication of streptoco

United States - English - NLM (National Library of Medicine)

apotex corporation - cefazolin sodium (unii: p380m0454z) (cefazolin - unii:ihs69l0y4t) - cefazolin for injection, usp is indicated in the treatment of the following serious infections due to susceptible organisms: respiratory tract infections: due to s. pneumoniae , klebsiella species, h. influenzae , s. aureus (penicillin-sensitive and penicillin-resistant), and group a beta-hemolytic streptococci. injectable benzathine penicillin is considered to be the drug of choice in treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cefazolin for injection, usp is effective in the eradication of streptococci from the nasopharynx; however, data establishing the efficacy of cefazolin for injection, usp in the subsequent prevention of rheumatic fever are not available. urinary tract infections: due to e. coli , p. mirabilis , klebsiella species, and some strains of enterobacter and enterococci. skin and skin structure infections: due to s. aureus (penicillin-sensitive and penicillin-resistant), group a beta-hemolytic streptococci, and other strains of st